Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version

Profile of registrant


Identification number in the register: 42561875992-94
Registration date: 07/06/11 19:20:50

The information on this organisation was last modified on 26/05/14 18:31:47
The date of the last annual update was 26/05/14 18:31:47

Registrant : Organisation or self-employed individual

Name/company name: AstraZeneca
Acronym: AZ
Legal status: Corporation
Website address:


Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  Sorriot Pascal
Position: CEO

Permanent person in charge of EU relations

Surname, Name: Mr  Fredrik Moen
Position: Director European Government Affairs

Contact details:

Contact details of organisation's head office: 2 Kingdom Street 
London W2 6BD
Telephone number: (+44) 20 7604 8000
Fax number: (+) 
Other contact information: Brussels Office:

Rue Egide Van Ophemstraat 110
B-1180 Brussels
phone: +32 (0)2 370 49 57

Goals / remit

Goals / remit of the organisation: AZ is a global research-based biopharmaceutical company. Our skills and resources are focused on discovering, developing and marketing medicines for some of the world’s most serious illnesses, including cancer, heart disease, neurological disorders such as schizophrenia, respiratory disease and infection. We employ over 50,000 people (44% in Europe, 23% in the Americas and 22% in Asia and 11% in the rest of the world).
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 2
Complementary information: One FTE plus several different persons who engage with EU institutions on ad hoc basis (assessed to one FTE put together).

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Fredrik Moen 06/08/14 04/08/15


Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:

AZ works to improve the business environment for the pharmaceutical sector in Europe so as to ensure a highly competitive European pharmaceutical industry that contributes actively to improving the health and quality of life of patients worldwide.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Competition
  • Customs
  • Economic and Financial Affairs
  • Enterprise
  • Environment
  • General and Institutional Affairs
  • Internal Market
  • Justice and Fundamental Rights
  • Public Health
  • Research and Technology
  • Trade


Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.

AstraZeneca is a member of the following organisations in Brussels: EFPIA, European Biotech Enterprises (EBE), Vaccines Europe (VE), International Diabetes Federation (IDF).

Financial data

Financial year: 01/2013 - 12/2013
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 450000  € - 500000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

The estimated amount is based on salary costs and the costs of overheads at the AZ Brussels office according to the proportion of employee time spent on interest representation to the EU institutions. To avoid double counting the amount excludes membership fees and payment of third parties also involved in interest representation.

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.